rel-(2S,4R)-1-(tert-butoxycarbonyl)-2-(methoxycarbonyl)piperidine-4-carboxylic acid

Catalog No.: 
ACDLTZ734
CAS No.: 
1221818-38-7
Molecular Formula: 
C13H21NO6
Molecular Weight: 
574.62
rel-(2S,4R)-1-(tert-butoxycarbonyl)-2-(methoxycarbonyl)piperidine-4-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$437.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namerel-(2S,4R)-1-(tert-butoxycarbonyl)-2-(methoxycarbonyl)piperidine-4-carboxylic acid
IUPAC Name(2R,4S)-1-(tert-butoxycarbonyl)-2-(methoxycarbonyl)piperidine-4-carboxylic acid--(2S,4R)-1-(tert-butoxycarbonyl)-2-(methoxycarbonyl)piperidine-4-carboxylic acid (1/1)
Molecular FormulaC13H21NO6
Molecular Weight574.62
SMILESO=C([C@H]1C[C@@H](C(OC)=O)N(C(OC(C)(C)C)=O)CC1)O
InChI KeyAWYHHFPRRXACRT-QUOODJBBSA-N
SynonymCis-1-(tert-Butoxycarbonyl)-2-(methoxycarbonyl)piperidine-4-carboxylic acid;1,2,4-Piperidinetricarboxylic acid, 1-(1,1-dimethylethyl) 2-methyl ester, (2R,4S)-rel-;rel-(2S,4R)-1-(tert-butoxycarbonyl)-2-(methoxycarbonyl)piperidine-4-carboxylic acid
CAS No.1221818-38-7

Synthetic Route by SureRoute

1. ACDLTZ734 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDLTZ734 route product structure diagram
    ACDLTZ7341221818-38-7
Inquiry

2. ACDLTZ734 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDLTZ734 route product structure diagram
    ACDLTZ7341221818-38-7
Inquiry

3. ACDLTZ734 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDLTZ734 route product structure diagram
    ACDLTZ7341221818-38-7
Inquiry

Comments (0)